Magnetic resonance imaging and late-life depression: potential biomarkers in the era of personalized medicine

Am J Psychiatry. 2008 Feb;165(2):166-8. doi: 10.1176/appi.ajp.2007.07111771.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Age Factors
  • Anisotropy
  • Biomarkers, Pharmacological*
  • Body Water / metabolism
  • Brain / metabolism*
  • Brain / ultrastructure
  • Citalopram / therapeutic use
  • Depressive Disorder, Major / diagnosis*
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / metabolism
  • Diffusion Magnetic Resonance Imaging / methods
  • Diffusion Magnetic Resonance Imaging / statistics & numerical data
  • Drug Design
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Magnetic Resonance Imaging / statistics & numerical data
  • Selective Serotonin Reuptake Inhibitors / therapeutic use

Substances

  • Biomarkers, Pharmacological
  • Serotonin Uptake Inhibitors
  • Citalopram